leisure time -WSS

leisure time

author：entertainment 2025-09-29 12:09:36 - browse：2773

A sign of Humana insurance company on a brick building — business coverage from STAT — Adobe

Medicare Advantage beneficiaries on Tuesday filed a class-action lawsuit alleging that the health insurance giant Humana illegally used an algorithm to prematurely cut off payment for rehabilitation care after patients suffered serious illnesses and injuries.

The suit, filed in U.S. District Court in Western Kentucky, argues Humana’s reliance on the algorithm, known as nH Predict, was part of a fraudulent scheme to reap a windfall by systematically denying claims to desperately ill people.

It is the second suit filed following a STAT investigation that found Medicare Advantage insurers nationwide are using the algorithm to cut off patients’ rehab care, forcing them to forgo treatment or pay thousands of dollars out of pocket. An earlier complaint was filed in November against the algorithm’s maker, NaviHealth, and the company that owns NaviHealth, UnitedHealth Group.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Report: NIH

leisure time

focus

WSS

Scientists successfully use ultrasound imaging to map brain activity

HCA discloses massive data breach affecting 11 million patients

Report: NIH

Threats against the LGBTQIA+ community intensifying: Department of Homeland Security

It's time to get medical device identifiers over the finish line

Elizabeth Holmes on track for early release from her 11

entertainment

leisure time

entertainment

Trump demands the U.S. pay no more for drugs than other countries … again

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

What does generative AI mean for health care? We asked experts

Living with Fabry disease, a condition that causes chronic pain

Virginia high school admissions case could be legal follow

Retired US general questions alleged Putin, Prigozhin meeting

Apple is now the first public company to be valued at $3 trillion

Lecanemab for Alzheimer's is coming. Is the health system ready?

Psychedelics group wrestles with new pharma identity

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

explore

Petition to FDA: Get the lead out of consumer hair dyes

Adam's Biotech Scorecard: Do Sarepta's exon

It's time to get medical device identifiers over the finish line

Iowa House, Senate pass 6

Health insurers say they are turning to AI to cut costs, improve care

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

knowledge

leisure time

focus

focus